Dermapharm Holding SE
Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.
DMP | F
Overview
Corporate Details
- ISIN(s):
- DE000A2GS5D8
- LEI:
- 5299009F0KNZINQQQK37
- Country:
- Germany
- Address:
- Lil-Dagover-Ring 7, 82031 Grünwald
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Dermapharm Holding SE is a manufacturer of patent-free branded pharmaceuticals and other healthcare products. Established in 1991, the company operates an integrated business model encompassing in-house research, development, production, and distribution. Its activities are primarily structured into two segments: "Branded pharmaceuticals and other healthcare products" and "Parallel import business." The company focuses on profitable, niche markets and implements a growth strategy that combines organic development with targeted acquisitions to expand its product portfolio and international footprint. Key assets include in-house R&D competence, a pipeline of development projects, and over 1,300 marketing authorizations for products such as over-the-counter medicines and herbal supplements.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-05 13:48 |
Report Publication Announcement
|
English | 4.0 KB | ||
| 2025-11-03 11:45 |
Director's Dealing
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
|
English | 6.3 KB | ||
| 2025-08-26 07:30 |
Earnings Release
Dermapharm confirms stable business development in H1 2025 and records EBITDA g…
|
English | 25.4 KB | ||
| 2025-08-26 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 1.5 MB | ||
| 2025-08-18 09:26 |
Report Publication Announcement
|
English | 4.0 KB | ||
| 2025-08-12 07:30 |
Earnings Release
Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
|
English | 15.1 KB | ||
| 2025-07-04 16:18 |
Director's Dealing
Dermapharm Holding SE: Wilhelm Beier, buy
|
English | 5.8 KB | ||
| 2025-07-01 12:30 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 12.3 KB | ||
| 2025-06-27 14:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.0 KB | ||
| 2025-06-26 17:43 |
Post-Annual General Meeting Information
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of…
|
English | 10.9 KB | ||
| 2025-06-24 16:46 |
Director's Dealing
Dermapharm Holding SE: Dr. Andreas Eberhorn, buy
|
English | 5.8 KB | ||
| 2025-06-05 12:29 |
Director's Dealing
Dermapharm Holding SE: Anja Schorn, buy
|
English | 6.2 KB | ||
| 2025-06-04 11:19 |
Director's Dealing
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
|
English | 6.9 KB | ||
| 2025-05-16 15:05 |
Pre-Annual General Meeting Information
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 2…
|
German | 59.4 KB | ||
| 2025-05-15 07:30 |
Earnings Release
Dermapharm Holding SE performs in line with projections in Q1 2025, confirms fu…
|
English | 23.6 KB |
Automate Your Workflow. Get a real-time feed of all Dermapharm Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dermapharm Holding SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dermapharm Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-30 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 54,530,000.00 EUR |
| 2024-12-30 | Beier, Wilhelm | Supervisory board | Buy | None | 3,895,000.00 EUR |
| 2024-11-15 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 6,464,000.00 EUR |
| 2024-11-11 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 95,185.00 EUR |
| 2024-11-05 | Dreibholz, Christof | Board | Buy | None | 27,720.00 EUR |
| 2024-10-23 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 19,704.55 EUR |
| 2024-08-29 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 29,954,600.00 EUR |
| 2024-06-11 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 101,778.57 EUR |
| 2024-05-22 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 8,577,500.00 EUR |
| 2023-06-27 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 99,902.36 EUR |
